 Connection
Benjamin Click to Gastrointestinal Agents
This is a "connection" page, showing publications Benjamin Click has written about Gastrointestinal Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.835 |
|
|
|
-
Click B, Regueiro M. A Practical Guide to the Safety and Monitoring of New IBD Therapies. Inflamm Bowel Dis. 2019 04 11; 25(5):831-842.
Score: 0.614
-
Click B, Regueiro M. Managing Risks with Biologics. Curr Gastroenterol Rep. 2019 Jan 11; 21(2):1.
Score: 0.603
-
Bachour SP, Shah RS, Joseph A, Syed H, Ali AH, Rieder F, Barnes EL, Axelrad J, Holubar SD, Regueiro M, Cohen BL, Click BH. Change in Biologic Class Promotes Endoscopic Remission Following Endoscopic Postoperative Crohn's Disease Recurrence. J Clin Gastroenterol. 2024 Sep 01; 58(8):810-817.
Score: 0.223
-
Shah RS, Bachour S, Jia X, Holubar SD, Hull TL, Achkar JP, Philpott J, Qazi T, Rieder F, Cohen BL, Regueiro MD, Lightner AL, Click BH. Hypoalbuminaemia, Not Biologic Exposure, Is Associated with Postoperative Complications in Crohn's Disease Patients Undergoing Ileocolic Resection. J Crohns Colitis. 2021 Jul 05; 15(7):1142-1151.
Score: 0.179
-
Franco DL, Click B. Proactive Versus Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: Is the Juice Worth the Squeeze? Inflamm Bowel Dis. 2020 01 01; 26(1):112-113.
Score: 0.161
-
Bhat S, Click B, Regueiro M. Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies. Inflamm Bowel Dis. 2024 05 02; 30(5):829-843.
Score: 0.054
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|